Western blot

Ansh Labs is a developer and manufacturer of immunoassay reagent test kits used to advance target discovery, therapeutic development, biomedical research, and clinical diagnostics. The company serves life science researchers, physician researchers, hospitals, commercial laboratories, and public health agencies, and its products support research in reproductive function, pregnancy, central nervous system, atherosclerotic cardiovascular disease, and oncology. Ansh Labs is now part of the VION Biosciences family of companies.

antibody development and screeningassay developmentassay optimizationassay validationCLIAELISAimmunoassay developmentimmunofluorescenceimmunohistochemistryluminogenic microplatemonoclonal antibody developmentneutralizing antibody

BIOQUAL is a specialist preclinical contract research organization (CRO) founded in 1981, providing comprehensive in vivo and in vitro preclinical research services to pharmaceutical, biotechnology, government, and academic organizations. The company focuses on infectious and human diseases, including virology, bacteriology, and parasitology, and also applies its capabilities to oncology and immunogenicity studies. Its labs operate up to Select Agent/BSL-3 standards and it is AAALAC-accredited.

BSL3 facilitiescell-based assayscustom animal model developmentcustom assay developmentcytotoxicity testingELISAELISpotFlow CytometryGLP servicesimagingimmunoassaysIND-enabling servicesin vitro researchin vivo researchLuminexpharmacokineticsPRNT and microneutralization assaystoxicology testingviral load assays

Diverge Translational Science Laboratory provides rigorous and quantitative assessments of tissue biomarkers and histopathology to support development of treatments for genetic diseases. Its expertise includes neuromuscular, cardiovascular, and neurodegenerative diseases, safety and toxicity studies, planning and coordinating biopsy studies, and regulatory compliance and reporting. The company began in 2022 with 2 founders and 8 employees who moved from academia to industry.

assay developmentautomated image analysisbiopsy study planning and coordinationcapillary westernhistologyregulatory compliance and reporting

EnquBio Inc is a San Diego-based drug R&D technology and service company (preclinical CRO) that advances pharmaceutical and biotechnology research through a comprehensive suite of drug discovery solutions. Located in San Diego's biotech hub, it operates state-of-the-art facilities led by an industry-recognized team, offering expertise in exploratory biology, high-throughput screening, SAR studies, in vitro and in vivo pharmacology, immunology-focused studies, biomarker discovery, and clinical sample analysis.

assay developmentbioanalysisbiomarker discoverycell line generationex vivo pharmacologygene expression analysisgenome editinghigh-content screeninghigh throughput screeningimmunoassayimmunophenotypingin vivo imagingin vivo pharmacologyiPSC platformnon-GLP toxicologyPK/PD analysis

Kimera Labs is an exosome biotechnology laboratory founded in 2012 by Duncan Ross, Ph.D., in Miramar, Florida. It produces perinatal mesenchymal stem cell (MSC)-derived exosome products for cosmetic and research purposes, operating from a 27,000 sq. ft. exosome-dedicated campus with ISO Class 5 hoods and ISO Class 7 cleanrooms and cGMP-compliant manufacturing.

AFMcell imagingcGMP manufacturingdSTORM super-resolution microscopyELISAHPLCMSC exosome production and isolationNTARNA-seqRT-PCRTEMultracentrifugation